BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 17470695)

  • 1. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.
    Moss AJ; Shimizu W; Wilde AA; Towbin JA; Zareba W; Robinson JL; Qi M; Vincent GM; Ackerman MJ; Kaufman ES; Hofman N; Seth R; Kamakura S; Miyamoto Y; Goldenberg I; Andrews ML; McNitt S
    Circulation; 2007 May; 115(19):2481-9. PubMed ID: 17470695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1.
    Ruwald MH; Xu Parks X; Moss AJ; Zareba W; Baman J; McNitt S; Kanters JK; Shimizu W; Wilde AA; Jons C; Lopes CM
    Heart Rhythm; 2016 Jan; 13(1):122-31. PubMed ID: 26318259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.
    Goldenberg I; Bradley J; Moss A; McNitt S; Polonsky S; Robinson JL; Andrews M; Zareba W;
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):893-901. PubMed ID: 20233272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to β-blocker therapy in type 1 long-QT syndrome.
    Barsheshet A; Goldenberg I; O-Uchi J; Moss AJ; Jons C; Shimizu W; Wilde AA; McNitt S; Peterson DR; Zareba W; Robinson JL; Ackerman MJ; Cypress M; Gray DA; Hofman N; Kanters JK; Kaufman ES; Platonov PG; Qi M; Towbin JA; Vincent GM; Lopes CM
    Circulation; 2012 Apr; 125(16):1988-96. PubMed ID: 22456477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.
    Jons C; Moss AJ; Lopes CM; McNitt S; Zareba W; Goldenberg I; Qi M; Wilde AA; Shimizu W; Kanters JK; Towbin JA; Ackerman MJ; Robinson JL
    J Cardiovasc Electrophysiol; 2009 Aug; 20(8):859-65. PubMed ID: 19490272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.
    Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L
    J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.
    Koponen M; Havulinna AS; Marjamaa A; Tuiskula AM; Salomaa V; Laitinen-Forsblom PJ; Piippo K; Toivonen L; Kontula K; Viitasalo M; Swan H
    BMC Med Genet; 2018 Apr; 19(1):56. PubMed ID: 29622001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients.
    Jons C; O-Uchi J; Moss AJ; Reumann M; Rice JJ; Goldenberg I; Zareba W; Wilde AA; Shimizu W; Kanters JK; McNitt S; Hofman N; Robinson JL; Lopes CM
    Sci Transl Med; 2011 Mar; 3(76):76ra28. PubMed ID: 21451124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Low-Risk Adult Congenital LQTS Patients.
    Zhang C; Kutyifa V; McNitt S; Zareba W; Goldenberg I; Moss AJ
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):853-858. PubMed ID: 25872798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of sudden cardiac death in a Swedish Y111C type 1 long-QT syndrome population.
    Winbo A; Diamant UB; Stattin EL; Jensen SM; Rydberg A
    Circ Cardiovasc Genet; 2009 Dec; 2(6):558-64. PubMed ID: 20031635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long QT syndrome in adults.
    Sauer AJ; Moss AJ; McNitt S; Peterson DR; Zareba W; Robinson JL; Qi M; Goldenberg I; Hobbs JB; Ackerman MJ; Benhorin J; Hall WJ; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
    J Am Coll Cardiol; 2007 Jan; 49(3):329-37. PubMed ID: 17239714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1.
    Thomas D; Khalil M; Alter M; Schweizer PA; Karle CA; Wimmer AB; Licka M; Katus HA; Koenen M; Ulmer HE; Zehelein J
    J Mol Cell Cardiol; 2010 Jan; 48(1):230-7. PubMed ID: 19540844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
    Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases.
    Winkel BG; Larsen MK; Berge KE; Leren TP; Nissen PH; Olesen MS; Hollegaard MV; Jespersen T; Yuan L; Nielsen N; Haunsø S; Svendsen JH; Wang Y; Kristensen IB; Jensen HK; Tfelt-Hansen J; Banner J
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1092-8. PubMed ID: 22882672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
    Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
    Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1.
    Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
    Gene; 2012 Dec; 511(1):26-33. PubMed ID: 23000022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.
    Barsheshet A; Moss AJ; McNitt S; Polonsky S; Lopes CM; Zareba W; Robinson JL; Ackerman MJ; Benhorin J; Kaufman ES; Towbin JA; Vincent GM; Qi M; Goldenberg I
    Circ Cardiovasc Genet; 2011 Oct; 4(5):491-9. PubMed ID: 21831960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.
    Heijman J; Spätjens RL; Seyen SR; Lentink V; Kuijpers HJ; Boulet IR; de Windt LJ; David M; Volders PG
    Circ Res; 2012 Jan; 110(2):211-9. PubMed ID: 22095730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
    Moretti A; Bellin M; Welling A; Jung CB; Lam JT; Bott-Flügel L; Dorn T; Goedel A; Höhnke C; Hofmann F; Seyfarth M; Sinnecker D; Schömig A; Laugwitz KL
    N Engl J Med; 2010 Oct; 363(15):1397-409. PubMed ID: 20660394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability.
    Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
    Biochim Biophys Acta; 2011 Apr; 1812(4):488-94. PubMed ID: 21241800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.